American College of Rheumatology
The American College of Rheumatology is an organization of and for physicians, health professionals, and scientists that advances rheumatology through programs of education, research, advocacy and practice support that foster excellence in the care of people with arthritis and rheumatic and musculoskeletal diseases.
Figures are based on itemized contributions reported to the Federal Election Commission and state agencies. Please note that:
- contributions under $200 are not reported, and so are not included in totals.
- only contributions from individuals and organizations to candidates are included. Various accounting measures and more exotic contribution types are excluded.
- contributions are matched based on organization and recipient name reported within each election cycle. Contributions using an incorrect or non-standard version of the name may be missed.
- corporate name changes and mergers may cause figures to differ from those of the Center for Responsive Politics.
- organization totals include known subsidiaries of the organization.
Latest FEC Datacovers through committee's December 31, 2012 filing.
Summaryoverview of the committee's finances
- Total Raised:
- Total Spent:
- Cash on Hand:
Standardized Donation Informationcovers roughly through Q3 2013. may lag behind FEC section above, as donors and industries are identified by hand.
- PAC Color Block
- Organization's PAC(s)
- Employee Color Block
- Associated Individuals
Republicans vs. Democratsin dollars
State vs. Federalin dollars
Figures are based on lobbying activity reported to the Senate Office of Public Records. Reported dollar amounts are required to be accurate only to the nearest $20,000. For organizations whose primary business is lobbying, we display total income and top clients. For organizations that are not primarily lobbying firms, we display total amount spent on lobbying and top lobbying firms hired.
For more information, please see our lobbying methodology page.
Lobbying on Behalf of American College of Rheumatology
Names of Lobbyists
Firm Hired Amount American College of Rheumatology $745,000
Most Frequently Disclosed Lobbying Issues
- Health Issues,
- Fed Budget & Appropriations,
- Medicare & Medicaid,
Most Frequently Disclosed Bills
Bill No. Title H.R.5 Help Efficient, Accessible, Low-cost, Timely Healthcare (HEALTH) Act of 2011 H.R.1700 Medicare Patient Empowerment Act H.R.2020 Preservation of Access to Osteoporosis Testing for Medicare Beneficiaries Act of 2011 H.R.452 Medicare Decisions Accountability Act of 2011 S.1042 Medicare Patient Empowerment Act S.1096 Preservation of Access to Osteoporosis Testing for Medicare Beneficiaries Act of 2011 H.R.2245 Preserving Access to Life-Saving Medications Act of 2011 S.296 Preserving Access to Life-Saving Medications Act S.668 Health Care Bureaucrats Elimination Act H.R.4209 Patients' Access to Treatments Act of 2012
RegulationsMentioned in 25 dockets; Submitted to 2 dockets
All data is based on documents downloaded from Regulations.gov. The first table shows mentions: all documents that include the name of the company anywhere in the document or document metadata. The second table shows submissions: all documents where the submitter metadata included the company name. Each table shows the top 10 dockets, ranked by number of occurrences.
Matches are based on a search for the company name. Variations in the company name, such as acronyms, nicknames or alternate names may cause documents to be missed. The mention of a company name in a document may be incidental and does not necessarily indicate that the company has any relevance to the document. Company names that are common English words may erroneously match with text that is not referring to the company.
Not all agencies submit public comments to Regulations.gov. For a list of participating and non-participating agencies see here. Agencies that do submit to Regulations.gov have varying levels of accuracy and completeness.
Regulations and public comments can be downloaded in bulk here.
The tables show occurrences of "American College of Rheumatology" in public comments on proposed federal regulations.
Documents Submitted by the Organization
View all submissions data for American College of Rheumatology
- Toggle 1 FDA Center for Drug Evaluation and Research, Approach to Addressing Drug Shortage; Public Workshop, Request for Comments 2011
- Toggle 1 HHS Health Information Technology; HIT Policy Committee: Request for Comment Regarding the Stage 3 Definition of Meaningful Use of Electronic Health Records (EHRs) 2012
Mentions in Document Text
View all mentions data for American College of Rheumatology
- Toggle 4 FDA Determine That the Drug Product Colchicine Table 0 3 mg 1 2 mg and 1 8 mg are Suitable for Submission as an Abbreviated New Drug Application ANDA 2012
- Toggle 3 CMS Medicare Program; Revisions to Payment Policies Under the Physician Fee Schedule, DME Face-to-Face Encounters, Elimination of the Requirement for Termination of Non-Random Prepayment Complex Medical Review and Other Revisions to Part B for CY 2013 (CMS-1590-P) 2012
- Toggle 2 CMS Medicare Program: Availability of Medicare Data for Performance Measurement 2011
- Toggle 2 CMS Medicare, Medicaid, Children's Health Insurance Programs; Transparency Reports and Reporting of Physician Ownership or Investment Interests (CMS-5060-P) 2011
- Toggle 2 CMS Certain Preventive Services Under the Affordable Care Act 2012
- Toggle 1 CMS Changes to the Electronic Prescribing (eRx) Incentive Program 2011
- Toggle 1 CMS Electronic Health Record Incentive Program – Stage 2 "Meaningful Use" 2012
- Toggle 1 FDA Draft Guidances Relating to the Development of Biosimilar Products; Public Hearing; Request for Comments 2011
- Toggle 1 CMS Reporting and Returning of Overpayments 2012
- Toggle 1 FDA Refrain From Approving any ANDA for a Colchicine Product Referencing Colcrys® That Omits the Familial Mediterranean Fever Clinical Risk Pregnancy Data From the Product's Labeling 2012
Federal Spending2 grants
Federal grants, contracts and loans are reported by federal agencies using the FPDS and FAADS systems. The data is made available to the public at USASpending.gov. Please note that the completeness and quality of the data varies greatly by agency.
Only grants, contracts and loans with amounts over $1 million are shown.
Because company names are not reported in a standardized manner, we cannot reliably determine the company receiving the contract or award. The results shown here are based on a search for the company name. Individual records may be missed or erroneously included because of name variations. For more information, please see our federal spending methodology page.
Note: Company names in federal spending data are not standardized. The table below is included only as a sample of what is available in the data and has not been reviewed for accuracy or completeness. To investigate the data further, use the links at the bottom of the table.
|American College Of Rheumatology||2011||Immed Office Of The Secretary Of Health And Human Services||FY11 LUPUS FOA||$1,000,000|
|American College Of Rheumatology||2012||Immed Office Of The Secretary Of Health And Human Services||THE COMMITMENT OF THE ACR'S EXISTING LUPUS INITIATIVE IS TO ELIMINATE CAUSES OF THE PERSISTENT GAPS BETWEEN THE LUPUS-RELATED HEALTH STATUS OF MINORI||$1,000,000|